The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
Open accessAbstract
Receptor activator of Nfkb ligand (RANKL) activates, while osteoprotegerin (OPG) inhibits, osteoclastogenesis. In turn a neutralizing Ab against RANKL, denosumab improves bone strength in osteoporosis. OPG also improves muscle strength in mouse models of Duchenne's muscular dystrophy (mdx) and denervation-induce atrophy, but its role and mechanisms of action on muscle weakness in other conditions remains to be investigated. We investigated the effects of RANKL inhibitors on muscle in osteoporotic women and mice that either overexpress RANKL (HuRANKL-Tg+), or lack Pparb and concomitantly develop sarcopenia (Pparb-/-). In women, denosumab over 3 years improved appendicular lean mass and handgrip strength compared to no treatment, whereas bisphosphonate did not. HuRANKL-Tg+ mice displayed lower limb force and maximal speed, while their leg muscle mass was diminished, with a lower number of type I and II fibers. Both OPG and denosumab increased limb force proportionally to the increase in muscle mass. They markedly improved muscle insulin sensitivity and glucose uptake, and decrease anti-myogenic and inflammatory gene expression in muscle, such as myostatin and protein tyrosine phosphatase receptor-γ. Similarly, in Pparb-/-, OPG increased muscle volume and force, while also normalizing their insulin signaling and higher expression of inflammatory genes in skeletal muscle. In conclusions, RANKL deteriorates, while its inhibitor improves, muscle strength and insulin sensitivity in osteoporotic mice and humans. Hence denosumab could represent a novel therapeutic approach for sarcopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Osteokines, novel exercise-inducible soluble factors secreted by osteocytes, osteo blasts, and osteoclasts, play an important role in the body’s response to exercise, mainly including RANKL [127], sclerostin [128], osteocalcin [129], fibroblast growth factor 23 (FGF23) [95], Wnt3a [130], TGF-β [131], IGF-1 [132], and prostaglandin E2 (PGE2) [133] (Figure 3).”
From Exerkines and Sarcopenia: Unveiling the Mechanism Behind Exercise-Induced Mitochondrial Homeostasis (2025) · cites this paper as [127]
In the citing paper
“Research has shown that RANKL inhibition improves muscle strength and insulin sensitivity in osteoporotic mice and humans through the RANK/RANKL/OPG signaling pathways, potentially representing a new therapeutic avenue for sarcopenia [127].”
From Exerkines and Sarcopenia: Unveiling the Mechanism Behind Exercise-Induced Mitochondrial Homeostasis (2025) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Mechanisms of Disease: is osteoporosis the obesity of bone?
Rosen, C. J., & Bouxsein, M. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0070 · Cited by 974
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17215 · Cited by 825 · cited 1×
“Increased expression of receptor activator of nuclear factor kappa-B ligand (RANKL) in postmenopausal women plays a central role in the development of osteoporosis (5).”
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martín, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 698
Trombetti, A., Reid, K. F., Hars, M., Herrmann, F. R., Pasha, E. P., Phillips, E. M., & Fielding, R. A. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3236-5 · Cited by 479
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐κΒ
LANGEN, R. C. J., Schols, A. M. W. J., KELDERS, M. C. J. M., Wouters, E. F. �., & Janssen-Heininger, Y. M. W. (2001) · The FASEB Journal · doi:10.1096/fj.00-0463 · Cited by 436
Microbiota depletion promotes browning of white adipose tissue and reduces obesity
Suárez-Zamorano, N., Fabbiano, S., Chevalier, C., Stojanović, O., Colin, D. J., Stevanović, A., Veyrat-Durebex, C., Tarallo, V., Rigo, D., Germain, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3994 · Cited by 403
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 315
Pacheco-Soto, B. T., Elguezabal-Rodelo, R. G., Porchia, L. M., Torres‐Rasgado, E., Pérez-Fuentes, R., & González-Mejía, M. E. (2021) · Journal of Drug Assessment · doi:10.1080/21556660.2021.1989194 · Cited by 18
Xu, H., Liu, S., Wang, Y., Wu, R., Yi, T., Wang, T., Zhu, Y., Fang, J., Xie, Y., Zhao, Q., et al. (2021) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2021.113878 · Cited by 18
Chronic Stress and Steatosis of Muscles, Bones, Liver, and Pancreas: A Review
Stefanaki, C., Paltoglou, G., Mastorakos, G. P., & Chrousos, G. P. (2022) · Hormone Research in Paediatrics · doi:10.1159/000522540 · Cited by 21
Osteosarcopenia and Pain: Do We Have a Way Out?
Bonanni, R., Grillo, S. G., Cariati, I., Tranquillo, L., Iundusi, R., Gasbarra, E., Tancredi, V., & Tarantino, U. (2023) · Biomedicines · doi:10.3390/biomedicines11051285 · Cited by 19
Mechanical loading recovers bone but not muscle lost during unloading
Krause, A. R., Speacht, T. L., Steiner, J. L., Lang, C. H., & Donahue, H. J. (2020) · npj Microgravity · doi:10.1038/s41526-020-00126-4 · Cited by 18
Role of the Osteocyte in Musculoskeletal Disease
Shimonty, A., Bonewald, L. F., & Pin, F. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00788-5 · Cited by 15
Role of RANKL Signaling in Bone Homeostasis
Sobacchi, C., Menale, C., Crisafulli, L., & Ficara, F. (2024) · Physiology · doi:10.1152/physiol.00031.2024 · Cited by 18
Ishikawa, K., Tani, S., Sakai, N., Kudo, Y., Horiuchi, H., Kimura, H., Takami, M., Tsuji, M., Inagaki, K., Kiuchi, Y., et al. (2025) · Bone Research · doi:10.1038/s41413-025-00433-0 · Cited by 19
Is sarcopenia associated with osteoporosis? A cross-sectional study of 262 women with hip fracture
Monaco, M. D., Castiglioni, C., Bardesono, F., Freiburger, M., Milano, E., & Massazza, G. (2022) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.22.07215-x · Cited by 17
Chang, Y., Hung, C., Chiang, Y.-Y., Chen, C., Liao, L., Huei‐Ming, M., Hwang, J., Hsu, C., Lee, C. B., Fu, S., et al. (2025) · Age and Ageing · doi:10.1093/ageing/afaf017 · Cited by 16
Mamedova, E., Kolodkina, A. A., Vasilyev, E., Petrov, V. M., Belaya, Z. E., & Tiulpakov, A. N. (2020) · Hormone Research in Paediatrics · doi:10.1159/000510625 · Cited by 16
Ma, J., Ye, M., Li, Y., Chai, S., Huang, H., Lian, X., & Huang, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111939 · Cited by 16
Sarcopenia: an unsolved problem after hip fracture
Park, J.-W., Kim, H.-S., Lee, Y., Yoo, J., Choi, Y., Ha, Y., & Koo, K. (2022) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-022-01334-6 · Cited by 16
Osteosarcopenia in Very Old Age Adults After Hip Fracture: A Real-World Therapeutic Standpoint
Pizzonia, M., Casabella, A., Natali, M., Petrocchi, L., Carmisciano, L., Nencioni, A., Molfetta, L., Giannotti, C., Bianchi, G., Giusti, A., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.612506 · Cited by 17
Treatment of Diabetes and Osteoporosis—A Reciprocal Risk?
Zawada, A. E., Ratajczak, A. E., Rychter, A. M., Szymczak‐Tomczak, A., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2022) · Biomedicines · doi:10.3390/biomedicines10092191 · Cited by 15
The inflammatory response, a mixed blessing for muscle homeostasis and plasticity
Bouredji, Z., Argaw, A., & Frenette, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1032450 · Cited by 19
Crosstalk between bone and muscle in chronic kidney disease
Wong, L., & McMahon, L. P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1146868 · Cited by 15
Osteoprotegerin mediates adipogenesis in obesity
Lyu, Z., Chan, Y.-T., Lu, Y., Lam, T. F., Wu, X., Wu, J., Xu, L., Yang, W., Zhang, C., Zhong, L. L. D., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.018 · Cited by 15
Little, S. E., Pagnotti, G. M., McGrath, C., & Styner, M. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00634-y · Cited by 15
Osteosarcopenia: epidemiology, molecular mechanisms, and management
Yi, Y.-T., Zhao, H.-F., Wang, W., & Li, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1577758 · Cited by 18
Wei, W., Li, Y., Li, Y., & Li, D. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.12.008 · Cited by 14
Lin, S., Tsou, S., Kuo, C.-Y., Chen, W., Wu, K., Lin, C., & Huang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210289 · Cited by 15
Jayash, S. N., Hamoudi, D., Stephen, L. A., Argaw, A., Huesa, C., Joseph, S., Wong, S. C., Frenette, J., & Farquharson, C. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01116-w · Cited by 14
Bonnet, N., Douni, E. K., Lopreno, G. P., Besse, M., Biver, E., & Ferrari, S. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4307 · Cited by 14
New insight into unexpected bone formation by denosumab
Wang, L., Huang, B., Chen, X., & Su, J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.001 · Cited by 13
Sharma, A. R., Chatterjee, S., Lee, Y., & Lee, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.00903 · Cited by 15
Takada, H., Yamashita, K., Osawa, L., Komiyama, Y., Muraoka, M., Suzuki, Y., Sato, M., Kobayashi, S., Yoshida, T., Takano, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50574-7 · Cited by 13
RANKL signaling drives skeletal muscle into the oxidative profile
de Araújo, P. H. C., Cezine, M. E. R., Vulczak, A., Vieira, L. C., Matsuo, F. S., Remoto, J. M., Santos, A. D. R., Miyabara, E. H., Alberici, L. C., & Osako, M. K. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae058 · Cited by 13
Evaluation of Body Composition in Paediatric Osteogenesis Imperfecta
Gilani, M., Shepherd, S., Nichols, B., Gerasimidis, K., Wong, S. C., & Mason, A. (2021) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2021.01.012 · Cited by 13
Kirk, B., Lieu, N., Vogrin, S., Sales, M., Pasco, J. A., & Duque, G. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac008 · Cited by 14
Liang, H., Wu, Q., Hua, T., Chen, Y., Luo, J., Miao, J., Su, H., Yang, S., Xu, J., Wang, X., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115589 · Cited by 13
Ran, J., Yang, J., Li, N., Yang, J., Yang, W., Chen, M., Sun, P., & Liao, Y. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06559-4 · Cited by 18
Osteopenia Is Associated with Shorter Survival in Patients with Intrahepatic Cholangiocarcinoma
Miki, A., Sakuma, Y., Watanabe, J., Endo, K., Sasanuma, H., Teratani, T., Lefor, A. K., Kitayama, J., & Sata, N. (2023) · Current Oncology · doi:10.3390/curroncol30020144 · Cited by 12
Hurley-Novatny, A. C., Chang, D., Murakami, K., Wang, L., & Li, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1398050 · Cited by 17
Watanabe, J., Miki, A., Sakuma, Y., Shimodaira, K., Aoki, Y., Meguro, Y., Morishima, K., Endo, K., Sasanuma, H., Lefor, A. K., et al. (2022) · Cancers · doi:10.3390/cancers14092213 · Cited by 12
Bone-Muscle Crosstalk: Musculoskeletal Complications of Chemotherapy
Hain, B. A., & Waning, D. L. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00749-4 · Cited by 12
Viggers, R., Al-Mashhadi, Z. K., Starup‐Linde, J., & Vestergaard, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.826997 · Cited by 13
Ramchand, S. K., Hoermann, R., White, S. C., Yeo, B. J., Francis, P. A., Xu, C. L. H., Zajac, J. D., Seeman, E., & Grossmann, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae003 · Cited by 11
Deciphering Osteosarcopenia through the hallmarks of aging
Franulic, F., Salech, F., Rivas, D., & Duque, G. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111997 · Cited by 14
Kaji, H. (2025) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2025.04.001 · Cited by 11
Functional capacity, sarcopenia, and bone health
Laskou, F., Patel, H. P., Cooper, C. C., & Dennison, E. M. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101756 · Cited by 12
Haeri, N. S., Perera, S., & Greenspan, S. L. (2022) · The Journal of Frailty & Aging · doi:10.14283/jfa.2022.54 · Cited by 11
Marcadet, L., Juracic, E. S., Khan, N., Bouredji, Z., Yagita∥, H., Ward, L. M., Tupling, A. R., Argaw, A., & Frenette, J. (2023) · Cells · doi:10.3390/cells12111538 · Cited by 11
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer
Cosentini, D., Pedersini, R., di Mauro, P., Zamparini, M., Schivardi, G., Rinaudo, L., Meo, N. D., Delbarba, A., Cappelli, C., Laganà, M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.50950 · Cited by 11
Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?
Sfeir, J. G., & Pignolo, R. J. (2021) · JBMR Plus · doi:10.1002/jbm4.10538 · Cited by 11
Wadiura, L. I., Butylina, M., Reinprecht, A., Aretin, M., Mischkulnig, M., Gleiß, A., Pietschmann, P., & Kerschan‐Schindl, K. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4694 · Cited by 12
Casabella, A., Paladin, F., Bighin, C., Ottaviani, S., Marelli, C., Ponzano, M., Signori, A., Murdaca, G., Cutolo, M., Molfetta, L., et al. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03725-1 · Cited by 9
Zhang, J., Sun, Z., Xu, L., Wang, Y., Wang, Y., & Dong, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1543003 · Cited by 9
Impact of denosumab on muscle health in older adults in long-term care
Haeri, N. S., Perera, S., & Greenspan, S. L. (2025) · Bone · doi:10.1016/j.bone.2025.117552 · Cited by 9
Perna, S., Gasparri, C., Allehdan, S., Riva, A., Petrangolini, G., Ferraris, C., Guido, D., Alalwan, T. A., & Rondanelli, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062269 · Cited by 9
Wu, R., Ma, Y., Chen, D., Li, M., Zeng, L., Deng, Z., Zheng, Q., & Fu, G. (2023) · Bone · doi:10.1016/j.bone.2023.116922 · Cited by 9
Shang, X., Zhang, X., Du, C., Ma, Z., Jin, S., Ao, N., Yang, J., & Du, J. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000410 · Cited by 9
Dimas, A., Politi, A., Bargiota, Α., Panoskaltsis, T., Vlahos, N., & Valsamakis, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158328 · Cited by 13
Lee, S., Song, D., Shin, S., Hong, N., & Rhee, Y. (2022) · Nutrition · doi:10.1016/j.nut.2022.111813 · Cited by 9
Guo, J., Ren, R., Guo, Z., Sun, K., He, J., Shao, J., & Wang, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109820 · Cited by 9
Evidence in humans for bone as an endocrine organ regulating energy metabolism
Khosla, S. (2023) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2023.100471 · Cited by 9
Nutritional Intervention and Musculoskeletal Health in Chronic Kidney Disease
Moldovan, D. T., Rusu, C. C., Potra, A. R., Tirinescu, D. C., Ţicală, M., Maslyennikov, Y., Bărar, A. A., Urs, A., & Kacsó, I. M. (2025) · Nutrients · doi:10.3390/nu17050896 · Cited by 8
Wan, Y., Chen, H., Hou, Y., Si, C., Zhao, Q., Wang, Z., Wang, L., & Guo, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19474 · Cited by 8
Ghimire, P. S., Eckart, A. C., Al-Makhzoomy, I. K., & Stavitz, J. (2023) · Sports · doi:10.3390/sports11110215 · Cited by 11
Improved Bone Quality and Bone Healing of Dystrophic Mice by Parabiosis
Li, H., Lu, A., Gao, X., Tang, Y. M., Ravuri, S. K., Wang, B., & Huard, J. (2021) · Metabolites · doi:10.3390/metabo11040247 · Cited by 8
Messages from the Mineral: How Bone Cells Communicate with Other Tissues
Plotkin, L. I., Sanz, N., & Brun, L. R. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01091-2 · Cited by 9
Melatonin having Therapeutic Bone Regenerating Capacity in Biomaterials
Huang, J., Li, Y., & He, C. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210709145347 · Cited by 8
Laurent, M. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-01782-8_61-1 · Cited by 8
Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia
Jang, S. Y., & Choi, K. M. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0093 · Cited by 9
Ha, J., Kim, J., Jeong, C., Lee, J., Lim, Y., & Baek, K. (2025) · Archives of Osteoporosis · doi:10.1007/s11657-024-01475-3 · Cited by 7
Role of Masticatory Force in Modulating Jawbone Immunity and Bone Homeostasis: A Review
Song, Y., Yao, J., Liu, Y., & Guo, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104478 · Cited by 7
Li, S., Hu, S., Zheng, X., Ku, X., Zou, J., Wang, L., Nie, G., Liu, Y., Tian, C., Ran, J., et al. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s547803 · Cited by 7
Aryana, I. G. P. S., Rini, S. S., & Setiati, S. (2023) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.22.0139 · Cited by 7
RetractedZhu, Q., Zhang, T., Cheang, I., Lu, X., Shi, M., Zhu, X., Liao, S., Gao, R., Li, X., & Yao, W. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06700-7 · Cited by 7
Tan, M., Zhu, S.-X., Wang, G.-P., & Liu, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-57352-z · Cited by 8
Cellular Contributors to Bone Homeostasis
Rauner, M., Jähn, K., Hemmatian, H., Colditz, J., & Goettsch, C. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-46725-8_16 · Cited by 6
Osteosarcopenia: pathogenesis, diagnosis and therapeutic approaches
Grebennikova, T. A., Тамерланович, Ц. Т., Vorobeva, J. R., & Belaya, Z. E. (2020) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1243 · Cited by 8
Ballato, E., Deepika, F., Prado, M., Russo, V., Fuenmayor, V., Bathina, S., Villareal, D. T., Qualls, C., & Armamento‐Villareal, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936159 · Cited by 7
Lü, N., Shan, C., Fu, J.-R., Zhang, Y., Wang, Y., Zhu, Y., Yu, J., Cai, J., Li, S., Tao, T., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020451 · Cited by 9
Rao, Q., Hua, H., & Zhao, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094277 · Cited by 8
Molecular communication from bone to skeletal muscle: an overview
Li, G., Qi, M., Wang, Y., Liang, S., & Xu, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1715009 · Cited by 10
Delayed denervation-induced muscle atrophy in Opg knockout mice
Zhang, M., Chen, M., Li, Y., Rao, M., Wang, D., Wang, Z., Zhang, L., Yin, P., & Tang, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1127474 · Cited by 6
A non-invasive mouse model that recapitulates disuse-induced muscle atrophy in immobilized patients
Wu, K., Lin, H., Chu, P., Li, C., Kao, H., Lin, C.-H., & Cheng, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-49732-8 · Cited by 6
Khan, M., Parshad, S., Naimi, M. F., Sidhu, A. K., Lyons, F., Hardisty, M., Whyne, C. M., Smoragiewicz, M., Phillips, C. M., Briones, J., et al. (2023) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2023.01.009 · Cited by 6
The Triple Burden of Osteoporosis, Sarcopenia, and Aging in Geriatrics (review)
Kurmaev, D. P., Bulgakova, S. V., Treneva, E. V., Kosareva, O. V., Sharonova, L. A., & Dolgikh, Y. A. (2024) · Russian Journal of Geriatric Medicine · doi:10.37586/2686-8636-3-2024-225-239 · Cited by 6
Pharmacologic Treatments to Preserve Bone and Muscle Mass in Osteosarcopenia
Klein, G. L. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00576-5 · Cited by 6
A bibliometric research based on hotspots and frontier trends of denosumab
Ren, B., Ren, X., Wang, L., Tu, C., Zhang, W., Liu, Z., Qi, L., Wan, L., Pang, K., Tao, C., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929223 · Cited by 6
Burn injury and restoration of muscle function
Klein, G. L. (2019) · Bone · doi:10.1016/j.bone.2019.115194 · Cited by 6
Hernandez-Martinez, J., Branco, B. H. M., Vásquez-Carrasco, E., Cid-Calfucura, I., Herrera-Valenzuela, T., Guzmán-Muñoz, E., Delgado‐Floody, P., Concha‐Cisternas, Y., & Valdés-Badilla, P. A. (2025) · Nutrients · doi:10.3390/nu17172852 · Cited by 5
Beyond bone effects: the role of denosumab in muscle Health – A systematic review
Ceolin, C., Ziliotto, C., Papa, M. V., Bertocco, A. G., Sergi, G., & RUI, M. D. (2026) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03285-0 · Cited by 6
Haeri, N. S., Perera, S., & Greenspan, S. L. (2023) · The Journal of Frailty & Aging · doi:10.14283/jfa.2023.38 · Cited by 6
Zusi, C., Bonetti, S., Rinaldi, E., Csermely, A., Boselli, M. L., Travia, D., Santi, L., Bonora, E., Bonadonna, R. C., & Trombetta, M. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3847 · Cited by 5
Rethinking Osteoporosis Drugs: Can We Simultaneously Address Sarcopenia?
Gavrilov, Z., & Lojk, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146924 · Cited by 7
Kan, B., Hou, J., Leslie, W. D., Jiang, D., Zhang, J., & Yang, S. (2023) · Bone · doi:10.1016/j.bone.2023.116738 · Cited by 5
Duque, E. J., Crispilho, S. F., Oliveira, I. B., Dominguez, W. V., Silva, C., Furukawa, L. N. S., Teng, A. K., Avesani, C. M., Shinjo, S. K., Elias, R. M., et al. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziae084 · Cited by 5
Laurent, M. R. (2024) · Springer eBooks · doi:10.1007/978-3-030-74720-6_61 · Cited by 5
Cigarettes Make You Weak: RANKL/RANK Link Changes in Muscle and Bone
Nogueira, L., & Breen, E. C. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0098ed · Cited by 6
Wang, X., Wu, M. F., Liu, Q., He, W., Tian, Y., Zhang, Y., Li, C., Liu, Y., Yu, A., & Jin, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1403822 · Cited by 4
Bone as an endocrine regulator of lipid and energy metabolism
Liu, H., Zhao, J., Liu, L., Ying, W., Liu, S., Luo, E., & Rosen, C. J. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10052-7 · Cited by 4
Beyond Bone: Embracing Osteosarcopenia for Comprehensive Fracture Prevention
Kim, B. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2002 · Cited by 4
Rouach, V., Gortler, H., Greenman, Y., Chodick, G., & Goldshtein, I. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1590472 · Cited by 4
Ahmed, F., Ahmad, S. S., Alam, M. M., Shaquiquzzaman, M., Altamish, M., Krishnan, A., Vohora, D., Najmi, A. K., & Khan, M. A. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae112 · Cited by 4
Prasad, T. N., Flora, S. S., Bhadada, S. K., Yadav, U., & Pal, R. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07599-7 · Cited by 4
Relationship Between Maternal Bone Biomarkers and Fetal Adiposity Through Normal Pregnancy
Mastorakos, G. P., Maliopoulos, D., Kasioni, S., Bargiota, Α., Barber, T. M., Skevaki, C. L., Papassotiriou, I., Vrachnis, N., Farmakides, G., Vlahos, N., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab152 · Cited by 4
Purification and Biological Function of Caldecrin
Tomomura, A., Bandow, K., & Tomomura, M. (2021) · Medicines · doi:10.3390/medicines8080041 · Cited by 4
Metadata
- Authors
- Bonnet, N., Bourgoin, L., Biver, E., Douni, E., & Ferrari, S.
- Affiliations
- University Hospital of Geneva (CH)
- Agricultural University of Athens (GR)
- Corresponding author
- Bonnet, Nicolas
- Venue
- Journal of Clinical Investigation
- Published
- 2019-07-02
- Volume
- 129
- Issue
- 8
- Pages
- 3214-3223
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6668701
- OpenAlex
- W2945787015
- Cited by
- 314
- References
- 41
- Citations by year
- 2026: 39 · 2025: 48 · 2024: 42 · 2023: 48 · 2022: 45 · 2021: 46 · 2020: 36 · 2019: 10
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Swiss National Science Foundation grant (No 3100A0-116633/1)
- European Foundation for the Study of Diabetes (ME1598)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- RANKL inhibition, denosumab, osteoprotegerin, muscle strength, insulin sensitivity, sarcopenia, osteoporosis, PPARδ, muscle atrophy, muscle fiber composition, myostatin, PTEN, skeletal muscle glucose uptake, muscle inflammation, bisphosphonates, osteoclastogenesis
- MeSH terms
- Denosumab, Animals, Bone and Bones, Cell Line, Female, Humans, Insulin Resistance, Male, Mice, Transgenic, Organ Size, Osteoporosis, PPAR-beta, Mice, Osteoprotegerin, RANK Ligand, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
